Literature DB >> 19067420

Upper gastrointestinal tract phenotype of Crohn's disease is associated with early surgery and further hospitalization.

Dorothy K L Chow1, Joseph J Y Sung, Justin C Y Wu, Kelvin K F Tsoi, Rupert W L Leong, Francis K L Chan.   

Abstract

BACKGROUND: According to the Montreal Classification, upper gastrointestinal tract phenotype L4 is uncommon in Caucasian patients with Crohn's disease (CD) but carries excess risk of recurrence. We studied the clinical course of CD in Chinese patients presenting with the L4 phenotype and factors predicting its occurrence upon longitudinal follow-up.
METHODS: This prospective cohort study included 132 Chinese CD patients (median age at diagnosis, 30.0 years, range: 14.0-77.0 years) who were followed for 770 person-years. Demographic data including disease behavior and location, details of surgery, and hospitalization were collected. The Kaplan-Meier method was used to estimate the probabilities of further hospitalization and major surgery followed by Cox proportional hazards regression to determine if clinical variables independently predicted the endpoints.
RESULTS: The L4 phenotype was found in 30 (22.7%) patients at presentation. There were significantly more stricturing (46.7% versus 18.6%) and penetrating (30.0% versus 3.9%) phenotypes in the L4 group than in the non-L4 group (P < 0.0001). The 3-year cumulative probability of further hospitalization was 86.9% (95% confidence interval [CI]: 73.8%-100.0%) in the L4 group as compared with 49.3% (95% CI: 39.3%-59.3%) in the non-L4 group (log-rank test, P < 0.0001). The L4 phenotype independently predicted further hospitalization (adjusted hazards ratio [HR]: 2.1; 95% CI: 1.3-3.5). The cumulative probability of major surgery was significantly higher in the L4 than in the non-L4 group (P < 0.0001). Eighteen (17.6%) patients developed the L4 phenotype on follow-up and the stricturing phenotype predicted its occurrence (adjusted HR: 5.5; 95% CI: 2.2-14.0).
CONCLUSIONS: Chinese CD patients more often had the L4 phenotype, which predicted the need of subsequent hospitalization.

Entities:  

Mesh:

Year:  2009        PMID: 19067420     DOI: 10.1002/ibd.20804

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  24 in total

1.  Predictors of aggressive inflammatory bowel disease.

Authors:  Andres J Yarur; Sebastian G Strobel; Amar R Deshpande; Maria T Abreu
Journal:  Gastroenterol Hepatol (N Y)       Date:  2011-10

Review 2.  Natural history and long-term clinical course of Crohn's disease.

Authors:  Hugh James Freeman
Journal:  World J Gastroenterol       Date:  2014-01-07       Impact factor: 5.742

3.  Factors That Predict High Health Care Utilization and Costs for Patients With Inflammatory Bowel Diseases.

Authors:  Julajak Limsrivilai; Ryan W Stidham; Shail M Govani; Akbar K Waljee; Wen Huang; Peter D R Higgins
Journal:  Clin Gastroenterol Hepatol       Date:  2016-09-17       Impact factor: 11.382

4.  Fourteen-Year Anti-TNF Therapy in Crohn's Disease Patients: Clinical Characteristics and Predictive Factors.

Authors:  Aisaku Osamura; Yasuo Suzuki
Journal:  Dig Dis Sci       Date:  2017-12-05       Impact factor: 3.199

5.  Risk factors for initial surgery in patients with Crohn's disease in Central China.

Authors:  Min Chen; Fengming Yi; Feng Zhou; Meifang Huang; Jin Li; Wenfeng Yan; Lixia Li; Bing Xia
Journal:  Surg Today       Date:  2014-12-20       Impact factor: 2.549

6.  Clinical Features and Prognosis of Crohn's Disease with Upper Gastrointestinal Tract Phenotype in Chinese Patients.

Authors:  Xiao-Wei Sun; Juan Wei; Zhao Yang; Xin-Xin Jin; Hai-Jun Wan; Bo-Si Yuan; Miao-Fang Yang; Jiong Liu; Fang-Yu Wang
Journal:  Dig Dis Sci       Date:  2019-05-11       Impact factor: 3.199

7.  Relationship between proximal Crohn's disease location and disease behavior and surgery: a cross-sectional study of the IBD Genetics Consortium.

Authors:  Mark Lazarev; Chengrui Huang; Alain Bitton; Judy H Cho; Richard H Duerr; Dermot P McGovern; Deborah D Proctor; Miguel Regueiro; John D Rioux; Philip P Schumm; Kent D Taylor; Mark S Silverberg; A Hillary Steinhart; Susan Hutfless; Steven R Brant
Journal:  Am J Gastroenterol       Date:  2012-12-11       Impact factor: 10.864

8.  The Impact of Magnetic Resonance Enterography and Capsule Endoscopy on the Re-classification of Disease in Patients with Known Crohn's Disease: A Prospective Israeli IBD Research Nucleus (IIRN) Study.

Authors:  Tomer Greener; Eyal Klang; Doron Yablecovitch; Adi Lahat; Sandra Neuman; Nina Levhar; Benjamin Avidan; Henit Yanai; Iris Dotan; Yehuda Chowers; Batya Weiss; Fred Saibil; Marianne M Amitai; Shomron Ben-Horin; Uri Kopylov; Rami Eliakim
Journal:  J Crohns Colitis       Date:  2016-01-08       Impact factor: 9.071

9.  How fast up the ladder? Factors associated with immunosuppressive or anti-TNF therapies in IBD patients at early stages: results from a population-based cohort.

Authors:  Claudia Ott; Angela Takses; Florian Obermeier; Elisabeth Schnoy; Bernd Salzberger; Martina Müller
Journal:  Int J Colorectal Dis       Date:  2014-09-03       Impact factor: 2.571

Review 10.  Practical Approaches to "Top-Down" Therapies for Crohn's Disease.

Authors:  Aranzazu Jauregui Amezaga; Gert Van Assche
Journal:  Curr Gastroenterol Rep       Date:  2016-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.